Skip to main content
OpenTrials

Clinical trial condition

Breast Lobular Carcinoma In Situ

Explore clinical trials studying Breast Lobular Carcinoma In Situ. Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Breast Lobular Carcinoma In Situ trial results

Recruiting

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

NCT06184750

Conditions
Adenocarcinoma, Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, +17 more
Locations
  • University of Arizona Cancer Center - Prevention Research Clinic Tucson, Arizona, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Illinois College of Medicine - Chicago Chicago, Illinois, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View Trial Details
Recruiting

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

NCT05941520

Conditions
Adenocarcinoma, Breast Atypical Hyperplasia, Breast Carcinoma, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions